A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

Author: Mita Monica   Rowinsky Eric   Forero Leonardo   Eckhart S.   Izbicka Elzbieta   Weiss Geoffrey   Beeram Muralidhar   Mita Alain   Bono Johann   Tolcher Anthony   Hammond Lisa   Simmons Paul   Berg Kristin   Takimoto Chris   Patnaik Amita  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.2, 2007-02, pp. : 165-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content